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Abstract: microRNAs (miRNAs) are short ~22 nucleotides (nt) ribonucleic acids which
post-transcriptionally regulate gene expression. miRNAs are key regulators of all cellular processes,
and the correct expression of miRNAs in an organism is crucial for proper development and cellular
function. As a result, the miRNA biogenesis pathway is highly regulated. In this review, we outline
the basic steps of miRNA biogenesis and miRNA mediated gene regulation focusing on the role of
RNA binding proteins (RBPs). We also describe multiple mechanisms that regulate the canonical
miRNA pathway, which depends on a wide range of RBPs. Moreover, we hypothesise that the
interaction between miRNA regulation and RBPs is potentially more widespread based on the
analysis of available high-throughput datasets.
Keywords: miRNA; RNA binding protein; Drosha; Dicer; Argonaute; cross-linking and
immonoprecipitation (CLIP)
1. Introduction
MicroRNAs (miRNAs) are an abundant class of small regulatory RNAs about 19–22 nucleotides
(nt) in length [1]. They have been predicted to regulate the expression of more than 60% of mammalian
genes and play fundamental roles in most biological processes including multiple diseases [2,3]. The
canonical miRNA pathway starts with the transcription of miRNA genes by RNA polymerase II,
which results in the production of the primary miRNA (pri-miRNA). The ~80 base pair long stem
loops of the pri-miRNAs are released from the primary transcript generating the precursor miRNA
(pre-miRNA). The pre-miRNA itself undergoes multiple processing steps before the mature miRNA is
finally generated [4]. Incorporated into one member of the Argonaute (Ago) protein family in the RNA
induced silencing complex (RISC), a mature miRNA binds typically to the 31 untranslated region (UTR)
of the targeted messenger RNA (mRNA) [1] and inhibits its translation via various mechanisms [5].
The key determinant of target recognition is a short sequence complementarity between the miRNA
seed sequence (the 2nd–8th nucleotides of the miRNA) and the targeted mRNA [6]. The maturation
and function of miRNAs are highly dependent on the coordinated action of several RNA-binding
proteins (RBP) [7]. Some of these proteins present unique protein domains that are characteristic of
proteins involved in small RNA processing and small RNA mediated gene regulatory events [8].
The processing and action of miRNAs are extensively regulated by auxiliary factors to ensure
cell/tissue specific functions or adequate response to environmental and cellular stimuli. One of the
largest groups of proteins that influence the miRNA pathways are RNA-binding proteins (RBP).
The application of advanced biochemical methods such as the use of a variety of cross-linking
immunoprecipitations (CLIPs) with the key proteins of the miRNA pathway, accelerated the
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identification of RBPs that are associated with complexes that are involved in miRNA processing or
bind to mRNAs that are targeted by miRNAs [9,10].
In this review, we describe the characteristics and functions of RBPs that are necessary for the
production of miRNAs and miRNA mediated gene expression as well as RBPs that regulate these
processes in mammalian cells. We have also carried out a basic bioinformatics exercise to compute the
potential scale of miRNA and RBP interactions using available CLIP data. Based on this we suggest a
more widespread interaction between RBPs and miRNA complexes in the targeting step of miRNA
mediated gene regulation.
2. RNA Binding Proteins in the miRNA Pathway
2.1. Core RNA Binding Proteins of miRNA Processing and miRNA Mediated Gene Regulation
2.1.1. Pri-miRNA Processing by the Microprocessor
The mammalian pri-miRNA contains a double stranded hairpin stem, a terminal loop and two
single stranded flanking regions [11]. Recent studies identified additional sequences and structural
elements that are necessary for efficient miRNA production. These include the length of the hairpin
stem structure, the UGU motif in the apical loop, a GHG motif in the stem, and a UG and CNNC motif
in the basal region of the pri-miRNA [12–14]. The first step in miRNA biogenesis is the recognition of
these motifs and the cleavage of the miRNA hairpins from the primary transcript. This is carried out by
the coordinated action of the Microprocessor complex. The Microprocessor is a heterotrimeric complex,
which is made up of two proteins: an RNA III enzyme Drosha, and two RNA-binding proteins DGCR8
(DiGeorge Critical Region 8) [12,15–18].
Drosha (also known as RNASEN) is a Class II RNase III enzyme that characteristically contains two
tandem RNase III domains and a dsRNA-binding domain. Drosha is an Mg2+ dependent endonuclease
that has roles in miRNA biogenesis, ribosomal RNA processing, and viral defence [19].
DGCR8, is the other component of the Microprocessor complex [15–17]. It contains a nuclear
localization signal, two dsRBDs (double stranded RNA-Binding domains), an RNA-binding heme
domain (Rhed), and a C-terminal tail (CTT) [11,20–22]. DGCR8 is dimerized through the Rhed domain
and binds to Drosha with its C-terminal region [20,23].
Recent biochemical data using purified recombinant Drosha and DGCR8 revealed that DGCR8
recognizes the apical UGU motif and binds to the pri-miRNA stem with its dsRBD domains. It also
stabilises Drosha with its CTT. In a cleavage competent Microprocessor, Drosha is positioned at the
basal UG motif that is at the junction of the single stranded flanking regions and the stem of the
hairpin [12]. Drosha cleaves the 51 and 31 arFms of the pri-miRNA, 11 base pairs away from the
single-stranded flank/double-stranded junction [18]. It was recently demonstrated that a CNNC motif,
downstream from the stem-ssRNA junction, is also required for efficient mammalian pri-miRNA
processing by the binding of the SRp20 splicing factor through its RNA recognition motif (RRM) [13]
(Figure 1a).
Both Drosha and DGCR8 have miRNA-independent functions. Drosha recognizes and cleaves
hairpins in mRNAs including the mRNA of DGCR8 that results in an auto regulatory circuitry of
the Microprocessor [24,25]. DGCR8 also has RNA-binding functions that are independent from the
Microprocessor. For example, a HITS-CLIP (hight-throughput sequencing of RNA isolated from
cross-linking immunoprecipitation) screening of RNA targets of DGCR8 in human cells revealed that
DGCR8 binds to and mediates cleavage of small nucleolar RNAs (snoRNAs) [10].
2.1.2. Pre-miRNA Processing
After Microprocessor processing, the resulting pre-miRNAs are exported from the nucleus to
the cytoplasm via the Exportin 5 pathway [26,27]. In the cytoplasm, pre-miRNAs are further cleaved
by Dicer, another RNAse III enzyme, with the help of RNA-binding co-factors which are Protein
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Kinase, Interferon-Inducible Double Stranded RNA Dependent Activator (PACT) and HIV-1 TAR
RNA-binding protein (TRBP) [28–31].
Dicer is a RNase III enzyme which contains an ATPase/RNA helicase, a PAZ domain (Piwi,
Argonaute and Zwille domain is a domain only present in proteins involved in small RNA mediated
gene regulation) [8], two catalytic RNase III domains, a domain of unknown function (DUF283) and
a C-terminal dsRBD [32]. Dicer was first recognised for cleaving dsRNA into small interfering RNA
(siRNA) [33,34] but was later discovered to also process miRNAs [28,29].
The PAZ domain of DICER binds to the 31 end of the small RNA substrates and also recognizes the
51 terminal phosphate of an authentic miRNA precursor [35–38]. The RNA helicase of Dicer recognises
the hairpin loop structures of pre-miRNAs and is able to differentiate between pre-miRNA and other
double stranded RNAs [39–42]. Dicer uses the region between its PAZ and RNase III domains as a
“molecular ruler” to produce small RNAs with consistent size [43]. Both RNase III domains of Dicer
cleaves the pre-miRNA with each RNase domain cleaving one strand of the small RNA duplex [44]
(Figure 1b).
Although Dicer is capable of cleaving pre-miRNA and dsRNA alone, its activity is modulated
by protein interactors. Two particular proteins well documented in this role are the related PACT
and TRBP [30,31]. Both of these Dicer binging proteins have three dsRBDs, one of which facilitates
protein-protein interaction by binding to the helicase domain of Dicer [45–47]. Both proteins stabilize
Dicer [48], affect the fidelity of miRNA processing [47,49,50] and influence the subsequent strand
selection of the miRNA [30,47,51].
2.1.3. Argonautes and the RNA Induced Silencing Complex (RISC)
Dicer cleavage produces a short (21–23 nt long) double stranded RNA with a characteristic 2
nt overhang at the 31 end [52,53]. One of the strands of the miRNA duplex is incorporated into an
Argonaute (Ago) protein, forming the minimal effector RNA induced silencing complex (RISC) [54–59].
Argonautes are bi-lobed proteins. They consist of an N-terminal , a PAZ domain (similar to the
PAZ domain found in Dicer), a middle (MID) domain and a PIWI domain [60–62]. The N-terminal
domain facilitates small RNA loading and the unwinding of the RNA duplex generated by Dicer [63].
The PAZ domain recognizes and anchors to the 31 end of the miRNA [64]. The MID domain binds the
51 terminal monophosphate moiety and the 51 terminal nucleotide of the miRNA guide strand. The
PIWI domain accommodates the miRNA-target RNA duplex, and it folds similarly to RNase H [60].
Ago2 (one of the four mammalian Argonautes) is the only Ago that possesses endonucleolytic
activity and can initiate the cleavage of the passenger strand of an extensively base-paired small RNA
duplex or the targeted mRNA if it is perfectly complementary to the Ago2 bound small RNA [60,65–68].
An increasing amount of evidence also suggests that cleavage competent Argonautes also play a role
in the processing of a pri-miRNA in C. elegans and in the Dicer dependent and independent maturation
of pre-miRNAs in mammals and worms [69–72].
2.1.4. RNA-Binding Proteins Involved in miRNA Mediated Gene Regulation
Since the majority of mammalian miRNAs only share limited complementary to their targets and
miRNAs also associate with Argonautes that lack endonuclease activity, target mRNA cleavage is a
rare event in mammals. Therefore, miRNAs in mammals mainly inhibit the translation of mRNAs and
degrade targeted RNA in a non-sequence specific manner. These processes also involve a range of
RNA-binding proteins.
The key proteins of a known mechanism of miRNA mediated translational repression and RNA
decay are the members of the TNRC6C/GW182 protein family [73]. They contain an N-terminal,
Gly and Trp (GW/WG) repeats in their Argonaute Hook Domain and a RNA recognition motif
(RRM) [74]. The TNRC6C protein binds to the PIWI domain of Ago through its GW/WG repeats and
localises Ago to the processing bodies (P-bodies) [75]. It also binds to the poly (A)-binding protein
(PABP) [76] inhibiting its interaction with the cap binding protein eIF4G that is necessary for translation
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initiation [77,78]. Ago bound TNRC6Cs also recruit the deadenylase complex CCR4-NOT (Carbon
catabolite repression 4-negative on TATA-less) which in turn recruits the DEAD box helicase DDX6
and facilitates the degradation of the miRNA target [76,79–82] (Figure 1c).
Recent studies in flies and mammalian systems showed that miRNAs could repress translation
in a GW182 independent way by inhibiting the formation of the eIF4F complex which recruits
the translationally competent mRNA to the ribosomes [83–85]. RISCs facilitate the release of
ATP-dependent RNA helicase proteins (eIF4A) from the eIF4F complex and therefore inhibit translation
of the miRNA targeted mRNA [84,85] (Figure 1d).
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2.2. RNA-Binding Proteins that Regulate miRNA Biosynthesis
miRNA processing is regulated at each step of the maturation pathway by multiple RBPs to ensure
tissue specific expression or proper response to environmental and cellular stimuli [4,7,86,87]. RBPs
can facilitate or inhibit miRNA processing either by recognizing and binding to RNA sequences or
structures, or altering the function of the machinery involved in a specific step of processing (Figure 2).
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2.2.1. The Regulation of Pri-miRNA Processing
Altering the structure of pri-miRNAs to r mote the binding or action of the Microprocessor is a
common form of regulating pri-miRNA processing. For example, p72 (DDX17) is a DEAD-box helicase
subunit of the Microprocessor [17,88,89] which facilitates pri-miRNA processing by binding to the 3’
flanking segments of the stem of the pri-miRNA hairpin [88,90,91]. While p72 is not required for the
efficient production of all miRNAs, the production of a large subset of miRNAs are inhibited by the
loss of p72 [88]. In addition, data generated by p72 CLIP experiments showed that 160 pri-miRNAs
bind to p72, and most of these associations were mapped to the stem of the pri-miRNAs [90]. p68
(DDX5) is also a DEAD-box helicase subunit of the Microprocessor compl x [17,89] that is required for
the efficient processing of a specific subs t f pre-miRNAs [92]. p68 recognizes the internal bulges of
the pri-mi NA stem and nwinds them i an ATP-dependent ma ner, which promotes the binding of
the Microprocessor complex [93].
RBPs can also regulate the processing of pri-miRNAs by recognizing and binding to the terminal
loop of the pri-miRNAs [94]. For example, the heterogenous ribonucleoprotein A1 (hnRNPA1) is
required for the efficient processing of pri-miR-18a, which is part of miR-17–92 cluster [95]. hnRNPA1
promotes pri-miR-18a processing by binding to its stem loop and generating a relaxed loop structure
that is more accessible for the Microprocessor and enhances Drosha cleavage [95]. Conserved miRNA
loops have been proposed to have the potent al to b nd other RBPs mainly from the hnRNP protein
family that may also influence pri-miRNA processing [96].
The loop can also provide a platform for proteins that inhibit pri-miRNA processing. For instance,
Lin28 negatively regulates let-7a biogenesis by binding to the pri-miRNA loop sequence which inhibits
the effective association of the Microprocessor [97].
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In addition to recognizing structures on pri-miRNAs, RBPs can influence pri-miRNA processing
via binding to specific sequences. Interestingly, hnRNPA1, besides promoting miR-18 processing,
can also have an inhibitory role in pri-miRNA processing. It binds to the GGG sequence of the
pri-let-7a loop and displaces another RBP, KHSRP, a KH-type splicing protein, which is necessary
for efficient pri-let-7a and pre-let-7a processing [94,98]. Another heterologous nuclear RNA-binding
protein, hnRNPA2B1 binds to m6A sites (a site of methylation of the N6 nitrogen in adenosine, the
most common internal modification of eukaryotic messenger RNA) located in the flanking regions of a
subset of pri-miRNAs and facilitates the recruitments of the Microprocessor complex [99]. pri-miR-7
processing is also facilitated by direct binding of an RBP. In this case Serine/Arginine-Rich Splicing
Factor 1 (SF2/ASF) recognises sequence motives on the miRNA stem region [100]. Fused in sarcoma
(FUS) binds to the GU-rich elements of pri-miRNAs and promotes pri-miRNA processing of a distinct
subset of miRNAs [101] (Figure 2a).
RBPs could also regulate pri-miRNA biogenesis by affecting the function of the Microprocessor
without apparent binding to pri-miRNAs. Early proteomics study showed that members of the FET
protein family, which is composed of FUS, EWS (Ewing Sarcoma protein) and TATA Box Binding
Protein Associated Factor, (TAF15) proteins, co-immunoprecipitate with the Microprocessor [17] and
subsequently all FET proteins have documented roles in the processing of miRNAs [102]. FUS controls
the biogenesis of a subset of miRNAs by directly interacting with the Microprocessor and recruiting
it to the transcription sites of miRNAs [101,103]. EWS affects miRNA biogenesis by inhibiting the
expression of Drosha possibly by binding to its promoter region [104].
2.2.2. The Regulation of Pre-miRNA Processing
Similar to pri-miRNA processing, the turnover and further maturation of pre-miRNAs are also
extensively regulated by auxiliary RBPs. The majority of these RBPs bind to the pre-miRNA and either
affect the stability of the RNA or modulate Dicer binding and/or function.
KHSRP regulates the processing of a subset of miRNAs by binding to G-rich regions of the
terminal loops of their precursors [98]. This binding promotes Dicer association to the pre-miRNA and
subsequently increases the cleavage rate of the precursors. TAR DNA-binding protein-43 (TDP-43)
regulates the processing of two miRNAs, pre-miR-143 and 547, by binding to UG rich motifs in
their respective terminal loops [105]. The cold-stress induced protein RBM3 regulates pre-miRNA
production through binding pre-let-7 and pre-miR-16 directly and promoting their association with
Dicer [106].
miRNA precursors can also be subjected to modifications and RNA nuclease activities that
decrease their stability and result in impaired miRNA production. The most extensively studied
mechanism that regulates miRNA turnover is the inhibition of miRNA processing mediated by Lin28.
Lin28 binds to GGAG sequences in the terminal loop of the pre-miRNA of let-7, miR-107, miR-143
and miR-200c and recruits two Terminal Uridylyl Transferases (TUTases) that polyuridynylate the
31 end of the pre-miRNA. This leads to the degradation of the precursor [107–109]. Currently, MCPIP1
(monocyte chemo attractant protein-MCP-induced Protein 1) is the only example of an endo-RNAse
that regulates the stability of select pre-miRNAs by endonucleolytic cleavage [110]. MCPIP1 cleaves
the terminal loops of the precursors which inhibit the binding of Dicer and accelerate the turnover
of the pre-miRNAs [110]. Dicer recognizes and cleaves pre-miRNAs that are monophosphorylated
at their 51 ends [38,111,112]. The RNA-methyltransferase BCDIN3D interferes with the processing
of pre-miR-145 by methylating its 51 nucleotide that prevents Dicer binding and processing [113]
(Figure 2b).
RBPs could also regulate miRNA biogenesis by affecting the expression or stability of the canonical
proteins of the miRNA pathway. For example, the RBP AU-binding factor 1 (AUF1) regulates the
general miRNA biosynthesis by inhibiting Dicer expression. AUF1 binds to the coding regions and the
31 UTR of the Dicer mRNA and accelerates its turnover and decreases its expression [114].
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2.2.3. Regulation of the Turnover of Mature miRNAs
An increasing number of studies show that the turnover rate of mature miRNAs are not
uniform suggesting the existence of regulatory mechanisms that regulate the stability of individual
miRNAs [115–117]. The exact mechanism of this phenomenon has not been revealed yet but RBPs that
degrade or modify mature miRNAs have been identified in a wide range of organisms [118].
In mammals 51 to 31 (XRN1) and 31 to 51 exonucleases (RRP41 and PNPase) have been
demonstrated to degrade a subset of miRNAs [119,120]. QKI, a member of the signalling transduction
and activation of RNA (STAR) family represents a unique regulatory mechanism in which QKI and its
isoforms directly bind to miR-20 and stabilize it [121] (Figure 2c).
2.2.4. RNA-Binding Proteins that Influence the Recognition and Regulation of miRNA Targets
In mammals, miRNAs mainly bind to the 31 UTR of the target mRNAs [122]. The 31 UTR is
also a hotspot for RNA-binding proteins that regulate maturation, stability, transfer, localization and
translation of mRNAs [123,124]. Therefore, it is inevitable that the miRNA loaded RISCs interact with
other RBPs when numerous RBPs may bind to the same 31 UTR. These interactions could result in the
inhibition of miRNA action either by competing for the same binding motif or restructuring the RNA
so that it becomes inaccessible for RISC complexes. On the other hand, RBPs could also change the
structure of the 31 UTRs to favour miRNA binding that facilitates miRNA mediated gene regulation.
A particular RBP could be either an inhibitor or an enhancer of miRNA targeting depending on the
context of its association with the mRNAs (Figure 3).
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Figure 3. RNA binding proteins ca promot and inhibit miRNA actio . ( ) Restructuring the target
RNA by RBPs could result in miRNA targeting; (b) RBPs assisting miRNA targeting via direct binding
to RNA induced silencing c mplex (RISC); (c) RBPs could restructure the target RNA and prevent
miRNA targeting; (d) RNA binding proteins (RBPs) and miRNA complexes can compete to target the
same mRNA via overlapping target sites.
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HuR (human antigen R) could regulate miRNA action through diverse mechanisms. For instance,
HuR was shown to compete with a few miRNAs over potential binding sites and could inhibit miRNA
targeting on select mRNAs (Figure 3d). It relieves the translational repression of TOP2A, CAT-1,
COX-2 and ERBB2 by masking the miRNA target sites for miR-548c-3p, miR-122, miR-16 and miR-331
respectively [125–127]. HuR could also inhibit miRNA mediated gene regulation by preventing the
RISC dependent dissociation of eIF4A from the translation initiation complex [85] (Figure 1d). On the
other hand, HuR could also facilitate miRNA mediated gene regulation. It promotes let-7a binding by
increasing binding site accessibility to the c-Myc 31 UTR [128] (Figure 3a).
Polyprimidine tract binding protein (PTB) or hnRNP, an RBP with well described function in
splicing and alternative splicing, also has dual functions in miRNA mediated gene regulation by
promoting or inhibiting miRNA targeting through an RNA dependent interaction with the RISC [129].
DND1 also inhibits the targeting potential of multiple miRNAs. Binding to the U rich
regions of target sites of miR-221 and miR-372, DND1 protects certain mRNAs from miRNA
mediated repression [130]. Interestingly, DND1 function in regulating miRNA mediated gene
expression is conserved since it regulates the accessibility of miRNAs in zebrafish to regulate early
development [131].
In cancer cells, coding region determinant binding protein (CRD-BP) competes with
miR-340 on the 31 UTR of MITF and with miR-183 on the βTrCP1 transcript preventing their
downregulation [132,133].
In addition, RNA Binding Motif Protein 38 (RBM38) inhibits miRNA targeting by binding to
U-rich region in the proximity of miRNA target sites [127].
2.3. Transcriptome Wide Identification of RBPs that Modulate miRNA Mediated Gene Regulation
Cross-linking immunoprecipitation (CLIP) using Ago specific antibodies is being used to
experimentally identify the Ago bound transcriptome that includes transcripts which are targeted
by miRNAs [9,134]. This method has also been used to identify the footprint of different RBPs on
whole transcriptomes [10,135–140]. Combining these approaches revealed that the interaction between
miRNA targeting and RBP binding are much more widespread than it was originally thought.
Ago2 CLIP combined with PTB knock down experiments showed that PTB could inhibit or
facilitate miRNA mediated gene regulation either to bind to miRNA target sites or restructure the
31 UTR of the co-targeted mRNAs [141]. PAR-CLIP analysis of Pumilo (PUM) revealed that PUM sites
co-localize 50 nt to the proximal region of specific miRNA sites and enhance miRNA action in human
B cells [142]. CLIP based analysis also revealed the interactions of two RBPs, Moloney Leukemia Virus
10 (MOV10) and Fragile X Mental Retardation Protein (FMRP), in regulating miRNA mediated gene
regulation. MOV10 was mapped to bind GC-rich sequences to facilitate miRNA targeting while FMRP
could counteract this cooperativity by binding to or near MOV10 sites [143].
Comparison of Ago2 (Argonaute 2) and RBPs (RNA Binding Proteins) Binding in HeLA Cells Using
Published CLIP Data
To investigate to what extent the binding site of AGO2 and other RBPs could overlap in a genomic
scale, we conducted a preliminary bioinformatics analysis in which we compared the results of
CLIP experiments carried out with a range of RBPs including Eukaryotic initiation factor 4AIII
(eIF4AIII) [136], hnRNPC [144], PTB [141], T-cell intracellular antigen 1 (TIA1) [145], TIA1-like
1 (TIAL1) [145], U2 small nucleolar RNA auxiliary factor 65 (U2AF65) [144] and Upframeshift
1 UPF1 [140] in HeLa cells and compared these data generated with Ago2 CLIP data [141]. Our
preliminary results show that a considerable number of RNAs identified by Ago2 CLIP overlap with
sequences bind to at least one other RBP (Table 1).
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Table 1. Identification of overlapping RBP and Ago2 binding sites
RBP Number of BindingSites




eIF4AIII 364,659 35,872 21%
hnRNPC 438,360 6422 4%
PTB 308,980 40,618 24%
TIA1 21,884 5029 3%
TIAL1 51,751 9029 5%
U2AF65 1,122,142 40,904 24%
UPF1 141,390 14,748 9%
The analysis of PAR-CLIP, HITS-CLIP and iCLIP datasets obtained from the StarBase
version 2 [146,147] shows that ~50% of Ago2 interaction sites in HeLa cells co-localize with the
binding site of at least one RBP (Table 1). Interestingly, we also found that the sequenced read numbers
are significantly (p < 0.05) higher if they are covering sites that are recognized by Ago2 and other RBPs.
This suggests that these sites are hotspots for RNA binding; therefore, inherently could be subjected to
interactions such as competition and/or cooperation between different RBPs.
3. Materials and Methods
Bioinformatics
CLIP-seq data (iCLIP, PAR-CLIP and HITS-CLIP) generated with AGO2 and multiple RBPs
including eIF4AIII, hnRNPC, PTB, TIA1, TIAL1, U2AF65 and UPF1 in HeLa cells were downloaded
from StarBase v2.0. The RBPs and Ago2 bound RNA fragments were mapped to human genome
version hg19. RNA fragments that were bound to AGO2 as well as to any of the analysed RBPs with
at least one nucleotide overlap were counted, and the corresponding sequencing read numbers were
quantified. A significant calculation was carried out using one paired t-test in SPSS statistics tool.
4. Conclusions
RBPs are key proteins not only involved in generating miRNAs and carrying out their function
but they also regulate miRNA processing and action at each step of the miRNA pathway. The
identifications of RBP binding sites on mRNAs using next generation sequencing suggest that RBPs
interaction with miRNA mediated gene regulation is potentially more widespread than the number of
the verified interactions would suggest. Most of the RBPs that have documented roles in the regulation
of the miRNA pathway act in a very specific environment. Therefore, it is highly likely that most of
these predicted potential interactions are the manifestation of responses to cellular or environmental
stimuli or specific to developmental stage or cell type.
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